Robert J Harris Selected Research

Robert J Harris Research Topics

Disease

21	Neoplasms (Cancer) 01/2023 - 06/2005
12	Glioblastoma (Glioblastoma Multiforme) 10/2018 - 01/2012
6	Melanoma (Melanoma, Malignant) 01/2023 - 01/2019
6	Glioma (Gliomas) 11/2018 - 08/2012
5	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 05/2015 - 10/2008
3	Infections 01/2022 - 11/2017
3	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 10/2008 - 06/2005
2	Brain Neoplasms (Brain Tumor) 11/2018 - 04/2013
2	Persistent Infection 11/2017 - 10/2014
2	Bacterial Infections (Bacterial Infection) 11/2017 - 10/2014
1	Autoimmune Diseases (Autoimmune Disease) 01/2023
1	Breast Neoplasms (Breast Cancer) 01/2021
1	Virus Diseases (Viral Diseases) 01/2021
1	Triple Negative Breast Neoplasms 01/2021
1	Stroke (Strokes) 01/2019
1	Ovarian Neoplasms (Ovarian Cancer) 01/2019
1	Inflammation (Inflammations) 01/2019
1	Ischemic Stroke 01/2019
1	Epilepsy (Aura) 12/2015
1	Tuberous Sclerosis (Bourneville's Disease) 12/2015
1	Blast Crisis (Blast Phase) 06/2011
1	Heart Failure 01/2011
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2011
1	Hairy Cell Leukemia 02/2007
1	Lymphadenopathy 06/2005

Drug/Important Bio-Agent (IBA)

5	Bevacizumab (Avastin)FDA Link 10/2018 - 08/2012
3	AntibodiesIBA 01/2023 - 01/2020
3	AntigensIBA 01/2023 - 01/2019
3	Biomarkers (Surrogate Marker)IBA 01/2020 - 08/2012
3	AminesIBA 11/2018 - 11/2015
3	Temozolomide (Temodar)FDA LinkGeneric 10/2018 - 09/2015
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2017 - 06/2005
3	Proteins (Proteins, Gene)FDA Link 07/2011 - 08/2006
2	Complementarity Determining Regions (Complementarity Determining Region)IBA 01/2023 - 01/2021
2	CytokinesIBA 01/2022 - 06/2005
2	Protons (Proton)IBA 11/2018 - 11/2016
2	MethyltransferasesIBA 10/2018 - 01/2012
2	cabozantinibIBA 01/2018 - 01/2017
2	Anti-Infective Agents (Microbicides)IBA 11/2017 - 10/2014
2	Anti-Bacterial Agents (Antibiotics)IBA 11/2017 - 10/2014
2	SilverIBA 11/2017 - 10/2014
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 05/2015 - 08/2006
2	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 03/2014 - 05/2013
2	Imatinib Mesylate (Gleevec)FDA Link 10/2009 - 10/2008
2	ChemokinesIBA 10/2008 - 06/2005
1	AutoantigensIBA 01/2023
1	Galectins (Galectin)IBA 01/2022
1	Folate Receptor 1IBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	IpilimumabIBA 01/2021
1	pembrolizumabIBA 01/2021
1	NivolumabIBA 01/2021
1	Immune Checkpoint ProteinsIBA 01/2021
1	Monoclonal AntibodiesIBA 01/2021
1	Antiviral Agents (Antivirals)IBA 01/2021
1	Immunoglobulin A (IgA)IBA 01/2021
1	Immunoglobulin D (IgD)IBA 01/2021
1	Immunoglobulin G (IgG)IBA 01/2021
1	Immunoglobulins (Immunoglobulin)IBA 01/2021
1	Viral RNAIBA 01/2021
1	Death Domain ReceptorsIBA 01/2021
1	Neutralizing AntibodiesIBA 01/2021
1	cyclopropapyrroloindoleIBA 01/2020
1	Blocking AntibodiesIBA 01/2019
1	ApolipoproteinsIBA 01/2019
1	HaptoglobinsIBA 01/2019
1	Immune Checkpoint InhibitorsIBA 01/2019
1	Oxygen (Dioxygen)IBA 11/2018
1	Proto-Oncogene Proteins c-metIBA 01/2018
1	Tyrosine Kinase InhibitorsIBA 01/2018
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 01/2018
1	Lomustine (CCNU)FDA Link 10/2017
1	paclitaxel poliglumex (XYOTAX)IBA 06/2017
1	trans-sodium crocetinate (crocetin)IBA 12/2015
1	Lactic Acid (Lactate)FDA LinkGeneric 11/2015
1	Leukotriene B4 Receptors (Leukotriene B4 Receptor)IBA 11/2014
1	Contrast MediaIBA 04/2014
1	alovudineIBA 08/2012
1	fluorodopa F 18IBA 08/2012
1	O-(6)-methylguanineIBA 01/2012
1	DNA (Deoxyribonucleic Acid)IBA 01/2012
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 06/2011
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2011
1	LipidsIBA 01/2011
1	Organic Cation Transporter 1IBA 10/2008
1	Dasatinib (BMS 354825)FDA Link 10/2008
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 02/2007
1	Protein Kinases (Protein Kinase)IBA 02/2007
1	IntegrinsIBA 06/2005
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 06/2005
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 06/2005

Therapy/Procedure

8	Therapeutics 01/2021 - 04/2013
3	Chemoradiotherapy 11/2015 - 03/2014
2	Immunotherapy 01/2021 - 01/2020
2	Aftercare (After-Treatment) 05/2015 - 11/2014
1	Drug Therapy (Chemotherapy) 01/2021
1	Radiotherapy 09/2015